Laba, T.L.Howard, K.Jan, S.2025-12-172025-12-172014Global Heart, 2014, vol.9, iss.1, supplement 1, pp.44-2211-8160https://hdl.handle.net/11541.2/117632Discrete Choice Experiment (DCE) is a preference elicitation method used to value healthcare technologies. Kanyini-GAP (KGAP), a pragmatic clinical trial, assessed a polypill-based strategy on patient adherence to cardiovascular disease (CVD) treatment in Indigenous and non-Indigenous Australians. In this context DCE could help understand patient preferences for treatment, assisting with clinical evidence translation.enCopyright 2014 Published by Elseviercardiovascular diseaseclinical trialtreatmentO161 Using DCE to assess adherence and treatment preferences for combination therapies for cardiovascular diseaseConference item10.1016/j.gheart.2014.03.1367